Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Feb 10, 2026The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $42.28B | $320.00 | -2.49% | $151.92M | 1,032.26x | 19.74 | United States | 43 |
| THC | TENET HEALTHCARE CORP | NYSE | Medical Care Facilities | A | $16.96B | $192.96 | -4.18% | $3.48B | 13.02x | 5.16 | United States | 31 |
| NBIX | NEUROCRINE BIOSCIENCES INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $13.91B | $139.56 | -1.16% | $679.20M | 32.38x | 0.42 | United States | 62 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | A | $10.03B | $165.00 | -0.30% | $182.64M | -27.55x | 1.87 | Ireland | 16 |
| VISN | VISTANCE NETWORKS INC | NASDAQ | Communication Equipment | A | $4.30B | $19.43 | 2.26% | $1.70B | 4.74x | -3.84 | United States | 24 |
| INDV | INDIVIOR PLC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $4.23B | $33.86 | -1.46% | $316.00M | 25.85x | -7.84 | United Kingdom | 36 |
| RSI | RUSH STREET INTERACTIVE INC | NYSE | Gambling | A | $4.06B | $17.70 | 0.17% | -$33.04M | 53.64x | 2.40 | United States | 50 |
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | A | $2.90B | $36.73 | 1.49% | $57.00M | 94.18x | 0.09 | United States | 45 |
| HCI | HCI GROUP INC | NYSE | Insurance - Property & Casualty | A | $2.08B | $160.73 | -1.57% | $301.16M | 9.31x | 1.82 | United States | 50 |
| HLMN | HILLMAN SOLUTIONS CORP | NASDAQ | Tools & Accessories | A | $2.02B | $10.25 | -2.19% | $249.21M | 51.25x | 0.95 | United States | 41 |
| FIVN | FIVE9 INC | NASDAQ | Software - Infrastructure | A | $1.33B | $17.04 | -0.23% | $127.81M | 40.57x | 1.28 | United States | 58 |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | NYSE | Capital Markets | A | $1.24B | $46.62 | -3.46% | $119.00M | 42.00x | 0.93 | United States | 35 |
| TBLA | TABOOLACOM LTD | NASDAQ | Internet Content & Information | A | $1.01B | $3.51 | -2.50% | $137.29M | 43.88x | 0.68 | United States | 41 |
| UVE | UNIVERSAL INSURANCE HOLDINGS INC | NYSE | Insurance - Property & Casualty | A | $857.17M | $30.56 | -3.63% | $174.52M | 6.98x | 5.24 | United States | 39 |
| NRDS | NERDWALLET INC | NASDAQ | Internet Content & Information | A | $746.04M | $10.26 | -2.66% | $98.00M | 10.58x | 0.23 | United States | 51 |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | NYSE | Specialty Retail | A | $705.28M | $18.90 | 5.18% | $145.14M | N/A | 6.80 | Mexico | 24 |
| LE | LANDS' END INC | NASDAQ | Apparel Retail | A | $568.25M | $18.60 | 3.39% | $86.84M | 50.27x | 2.69 | United States | 31 |
| ORGO | ORGANOGENESIS HOLDINGS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $486.07M | $3.83 | 1.59% | $18.04M | -31.92x | 0.49 | United States | 20 |
| LTRX | LANTRONIX INC | NASDAQ | Communication Equipment | A | $250.85M | $6.32 | 2.27% | -$4.74M | -27.48x | 0.64 | United States | 17 |
| ELMD | ELECTROMED INC | NYSEMKT | Medical Devices | A | $230.28M | $27.61 | -5.15% | $12.05M | 28.46x | 0.20 | United States | 51 |
| INFU | INFUSYSTEM HOLDINGS INC | NYSEMKT | Medical Instruments & Supplies | A | $155.78M | $7.66 | -0.78% | $24.16M | 29.46x | 0.78 | United States | 45 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.